Navigation Links
NeedyMeds.org Offers Information on Drug Discount Coupon
Date:12/16/2008

NeedyMeds.org, the most comprehensive source of information on pharmaceutical patient assistance programs, now has information on drug coupon programs. These programs offer free medicine and rebates for the cost of drugs.

(Vocus) December 16, 2008 -- NeedyMeds now helps with the high cost of medications by listing manufacturer's drug discount coupons. With these coupons patients can get free medications or rebates on purchased drugs. NeedyMeds is now the best source of information on these coupons.

Many patients and physicians are unaware of this way to save money on numerous prescription medicines. NeedyMeds has information on nearly 200 coupons. As with all the information on NeedyMeds.org, the information is free, easy to access, and updated regularly.

In cooperation with Xubex Pharmaceuticals, NeedyMeds offers patients the option of completing the coupon requests online and having their medications sent directly to their homes. Xubex handles all the paperwork by contacting the physicain's office for the patient, simplifying the process as coupons require a prescription from a doctor.

NeedyMeds, a Massachusetts-based non-profit, is the best source of information on assistance available for people having difficulties paying for their medications or healthcare. The website (http://www.needymeds.org) is visited by approximately 10,000 people each work day. All the NeedyMeds' information is always free, easy to access, and updated regularly. Unlike similar sites, NeedyMeds requires no registration. All the information is easily printed.

The website provides information on resources that help people with health-related costs:

  • Pharmaceutical patient assistance prog
    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Fresho.Com Offers Efficient Job Postings for Employers and Recruiters
2. Just in Time for the Holiday Rush, Braintree Stylist Bruce Fisher Offers Holiday Style & Beauty Tips
3. Physical therapy offers evidence-based solution to musculoskeletal pain
4. True Data Offers New Special Leasing Rates on Dialogic, Samsung, & Vertical Communications Products
5. How to Change Someone You Love Seminar Offers Help to Those Who Feel Powerless in the Face of Addiction
6. Partnership for Prevention Offers Health Reform Recommendations to Congress
7. Reid Supply Offers Free Educational Technical Resource Guides
8. All Nursing Schools Offers Continuing Education Resources
9. NSF International Offers Answers to Rising Toy Safety Concerns
10. In-House Hospice Offers Help to Those Living With Grief During Holiday Time
11. John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10BioCryst Provides Update Regarding Peramivir for Influenza 5116 1BioCryst Provides Update Regarding Peramivir for Influenza 5116 2BioCryst Provides Update Regarding Peramivir for Influenza 5116 3BioCryst Provides Update Regarding Peramivir for Influenza 5116 4BioCryst Provides Update Regarding Peramivir for Influenza 5116 5Study explores how life experiences contribute to the biological changes of Alzheimers 10197 1Study explores how life experiences contribute to the biological changes of Alzheimers 10197 2Study explores how life experiences contribute to the biological changes of Alzheimers 10197 3Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2